History and Future Perspectives on the Discipline of Quantitative Systems Pharmacology Modeling and Its Applications
Mathematical biology and pharmacology models have a long and rich history in the fields of medicine and physiology, impacting our understanding of disease mechanisms and the development of novel therapeutics. With an increased focus on the pharmacology application of system models and the advances i...
Saved in:
Published in | Frontiers in physiology Vol. 12; p. 637999 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
25.03.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Mathematical biology and pharmacology models have a long and rich history in the fields of medicine and physiology, impacting our understanding of disease mechanisms and the development of novel therapeutics. With an increased focus on the pharmacology application of system models and the advances in data science spanning mechanistic and empirical approaches, there is a significant opportunity and promise to leverage these advancements to enhance the development and application of the systems pharmacology field. In this paper, we will review milestones in the evolution of mathematical biology and pharmacology models, highlight some of the gaps and challenges in developing and applying systems pharmacology models, and provide a vision for an integrated strategy that leverages advances in adjacent fields to overcome these challenges. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 Edited by: Yoram Vodovotz, University of Pittsburgh, United States This article was submitted to Systems Biology, a section of the journal Frontiers in Physiology Reviewed by: Hugo Geerts, In Silico Biosciences, United States; Tarek A. Leil, Bristol Myers Squibb, United States; Ioannis P. Androulakis, Rutgers, The State University of New Jersey, United States Nathaniel J. Merril, Pacific Northwest National Laboratory, Computational Biology Group, Richland, WA, United States Present address: Chanchala D. Kaddi,Translational Disease Modeling, Data and Data Science, Sanofi, Cambridge, MA, United States |
ISSN: | 1664-042X 1664-042X |
DOI: | 10.3389/fphys.2021.637999 |